Insulin glargine, recombinant Subcutaneous and Stadol NS nasal
Determining the interaction of Insulin glargine, recombinant Subcutaneous and Stadol NS nasal and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: insulin glargine
Brand name: Basaglar KwikPen, Lantus, Lantus Solostar Pen, Toujeo SoloStar, Lantus OptiClik Cartridge, Toujeo Max SoloStar, Lantus SoloStar
Synonyms: Insulin glargine, Insulin Glargine
Generic Name: butorphanol
Brand name: Stadol NS, Stadol
Synonyms: Stadol NS (nasal), Stadol
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Insulin glargine, recombinant Subcutaneous-Stagesic
- Insulin glargine, recombinant Subcutaneous-Stahist AD
- Insulin glargine, recombinant Subcutaneous-Stahist AD (Chlorcyclizine and Pseudoephedrine Liquid)
- Insulin glargine, recombinant Subcutaneous-Stahist AD (Chlorcyclizine and Pseudoephedrine Tablets)
- Insulin glargine, recombinant Subcutaneous-Stalevo
- Insulin glargine, recombinant Subcutaneous-Stalevo 100
- Stadol NS nasal-Insulin glulisine
- Stadol NS nasal-Insulin Glulisine (Cartridges and Pens)
- Stadol NS nasal-Insulin Glulisine (Vials)
- Stadol NS nasal-Insulin glulisine Subcutaneous
- Stadol NS nasal-Insulin human inhaled Inhalation
- Stadol NS nasal-Insulin human regular Injection